Highlights
- BrainChip released Sequora intellectual property for edge generative AI in October.
- Approximately 20,000 AKD1500 chips arrived to support customer orders and boards.
- Customer cash inflows reached US$0.3 million in the September quarter.
- Quarter-end cash was US$16.4 million, about four quarters of reported runway.
BrainChip Holdings Ltd (ASX:BRN) develops neuromorphic processors and related intellectual property for artificial intelligence at the edge of networks. Its September 2026 quarterly update brought a combination of product availability, customer evaluation tools and licensing milestones. The distinction between delivering chips for testing and earning production-scale royalties remains particularly important. BrainChip’s reported operating figures show some commercial activity, while its technology roadmap depends on customers completing their own chip-design and production stages.
AKD1500 Hardware Moves Into Customer Hands
During the September quarter, the company received approximately 20,000 AKD1500 chips, supporting outstanding customer orders and production of evaluation hardware. It had received an initial 2,000 chips in June before beginning fulfilment in July. The M.2 development board was commercially released in July, followed by a PCIe development board announced in September. These formats give engineering teams different ways to evaluate the processor in their own systems.
The company also announced an SPI-connected AKD1500 variant in October for devices based on microcontrollers. Rather than requiring a complete processor redesign, the interface is intended to make neuromorphic functions accessible to a wider class of hardware. Commercial availability and evaluation activity are useful milestones, but do not disclose the number of customers that will reach high-volume production.
Sequora Extends the Intellectual Property Range
In October, BrainChip commercially released Sequora IP for edge-based generative AI and large-language-model inference. The development broadens the company’s portfolio beyond earlier Akida applications focused on sensor processing and classification. Bringing inference closer to a device can matter where latency, connectivity or energy requirements constrain cloud-based processing.
The release represents an additional technology offering, not an immediately quantified Revenue stream. Customer designs require software evaluation, system integration and commercial decisions before a licence translates into production royalties. The distinction matters as BrainChip expands both its hardware sales and intellectual property activity.
Developer Partnerships Support Evaluation
During July, the AKD1500 M.2 module was added to the CELUS design-automation platform, while Supplyframe made AKD1500 technology discoverable in its engineering software. In August, BrainChip announced work with Orama.AOI on automated optical inspection and with Neuromorphyx on developer hardware. The partnerships address a practical barrier in semiconductor adoption: customers need accessible development tools and reference designs before committing engineering resources.
At Embedded World North America in September, demonstrations covered radar classification, human detection and fall detection. These examples illustrate potential uses, although demonstrations alone do not provide evidence of commercial deployment levels. The September report also identified future tape-outs expected for licensed designs involving EdgeAI and Frontgrade Gaisler.
Quarterly Cash and Licensing Timing
For the September quarter, BrainChip reported US$0.3 million in customer cash inflows compared with US$0.1 million in the previous quarter. Payments to suppliers and employees were US$5.0 million, against US$5.1 million previously. Ending cash was US$16.4 million, which the company described as approximately four quarters of runway. This highlights the continuing gap between commercial receipts and operating expenditure.
The company identified support for customer tape-outs, conversion of pipeline opportunities, AKD2500 development and Sequora engagements among its priorities. The scale and timing of potential Royalty receipts will depend on licensees completing engineering milestones and entering production; such outcomes should not be assumed from licensing announcements alone.
Key Insights
BrainChip’s September 2026 update combined AKD1500 chip supply, new evaluation boards, developer partnerships and an expanded IP portfolio. The reported increase in customer cash inflows is measurable but small relative to quarterly supplier and employee payments. Sequora and licensee tape-outs provide possible next stages, while the US$16.4 million cash balance makes delivery timing and revenue conversion central to assessing progress.






Please wait processing your request...